Skip to main content
SpringerLink
Log in

Confusion about the tissue distribution of lymphokine-activated killer (LAK) cells

  • Letter to the editors
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ames IH, Gagne GM, Garcia AM, John PA, Scatorchia GM, Tumar RH, McAfee JG (1989) Preferential homing of tumor-infiltrating lymphocytes in tumor bearing mice. Cancer Immunol Immunother 29: 93

    PubMed  Google Scholar 

  2. Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH (1991) Accumulation of adoptively transferred adherent lymphokine-activated killer cells in murine metastases. J Exp Med 174: 479

    PubMed  Google Scholar 

  3. Basse P, Herberman RB, Hokland M, Goldfarb RH (1992) Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer Immunol Immunother 34: 221

    PubMed  Google Scholar 

  4. Felgar RE, Hiserodt JC (1990) In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor bearing rats. Cell Immunol 129: 288

    PubMed  Google Scholar 

  5. Fisher B, Packard BS, Read EJ, Carrasquillo JA, Carter CS, Topalian SL, Yang JC, Yolles P, Larson SM, Rosenberg SA (1989) Tumor localization of adoptively transferred Indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 7: 250

    PubMed  Google Scholar 

  6. Futami H, Pilaro AM, Gruys ME, Back TC, Young HA, Wiltrout RH (1991) In vivo distribution and cytokine gene expression by enriched mouse LAK effector cells. Biother 3: 219

    Google Scholar 

  7. Hercend T, Farace F, Baume D, Charpentier F, Droz JP, Triebel F, Escudier B (1990) Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma. J Biol Response Mod 9: 546

    PubMed  Google Scholar 

  8. Hornung RL, Salup RR, Wiltrout RH (1989) Tissue distribution and localization of IL-2-activated killer cells after adoptive transfer in vivo. In: Lotzova E, Herberman RB (eds) Interleukin-2 and killer cells in cancer. CRC Review. CRC, Boca Raton, Fla, p 246

    Google Scholar 

  9. Hosokawa M, Sawamura Y, Morikage T, Okada F, Yu Z-Y, Morikawa K, Itoh K, Kobayashi H (1988) Improved therapeutic effects of interleukin-2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide. Cancer Immunol Immunother 26: 250

    PubMed  Google Scholar 

  10. Lotze MT, Line BR, Mathieson DJ, Rosenberg SA (1980) The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implication for adoptive immunotherapy of tumors. J Immunol 125: 1487

    PubMed  Google Scholar 

  11. Maghazachi AA, Fitzgibbon L (1990) Fate of intravenously administered rat lymphokine-activated killer cells labelled with different markers. Cancer Immunol Immunother 31: 139

    PubMed  Google Scholar 

  12. Maghazachi AA, Goldfarb RH, Herberman RB (1988) Rat lymphokine activated killer (LAK) cells do not migrate toward sites of tumor growth: modulation of their normal distribution by carbohydrates (abstract). Nat Immun Cell Growth Regul 7: 52

    Google Scholar 

  13. Maghazachi AA, Herberman RB, Vujanovic NL, Hiserodt JC (1988) In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells. Cell Immunol 15: 179

    Google Scholar 

  14. Maghazachi AA, Goldfarb RH, Kitson RP, Hiserodt JC, Giffen CA, Herberman RB (1989) In vivo tissue distribution of interleukin-2 activated cells. In: Lotzova E, Herberman RB (eds) Interleukin-2 and killer cells in cancer. CRC Review. CRC, Boca Raton, Fla, p 260

    Google Scholar 

  15. Marincola FM, Drucker BJ, Keeling CA, Siao DY, Starnes HF, Goodwin DA, Holder WD (1989) Lymphokine-activated killer cells adoptively transferred in human pancreatic cancer-bearing nude mice. Surgery 105: 79

    PubMed  Google Scholar 

  16. Mukherji B, Arnbjarnarson O, Spitznagle LA, Kalish RI, Hoffman J, Ergin MT, Spencer RP (1988) Imaging pattern of previously in vitro sensitized and interleukin-2 expanded autologous lymphocytes in human cancer. Nucl Med Biol 15: 419

    Google Scholar 

  17. Ratner S (1990) Lymphocytes stimulated with recombinant human interleukin-2; relationship between motility into protein matrix and in vivo localization in normal and neoplastic tissues of mice. J Natl Cancer Inst 82: 612

    PubMed  Google Scholar 

  18. Rodolfo M, Salvi C, Bassi C, Sensi M, Parmiani G (1990) Adoptive immunotherapeutic treatments with interleukin-2 and lymphocytes in a mouse colonic adenocarcinoma model. Ann 1st Super Sanita 26: 423

    Google Scholar 

  19. Rodolfo M, Salvi C, Parmiani G (1989) Influence of the donors' clinical status on in vitro and in vivo tumor cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs. Cancer Immunol Immunother 28: 136

    PubMed  Google Scholar 

  20. Steen PD, McGregor JR, Lahman CM, Samlowski WE (1990) Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure. J Immunol 143: 4324

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. North Eastern Ontario Regional Cancer Centre, Laurentian University, Faculty of Medicine, University of Ottawa, 41 Ramsey Lake Road, P3E 5J1, Sudbury, Ontario, Canada

    Azzam A. Maghazachi

Authors
  1. Azzam A. Maghazachi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maghazachi, A.A. Confusion about the tissue distribution of lymphokine-activated killer (LAK) cells. Cancer Immunol Immunother 35, 426–427 (1992). https://doi.org/10.1007/BF01789023

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01789023

Keywords

Search

Navigation